LASIX: FUROSEMIDE INJECTION.
The FUROSEMIDE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAMUSCULAR OR INTRAVENOUS, special_features: 10MG FUROSEMIDE PER ML; 10ML VIALS, primary_container_type: VIAL, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-254-5546, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAMUSCULAR OR INTRAVENOUS |
| special_features | 10MG FUROSEMIDE PER ML; 10ML VIALS |
| primary_container_type | VIAL |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 10.000 MILLILITERS |
| active_medicament_medicinal_strength | 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER |
| part_name_assigned_by_controlling_agency | FUROSEMIDE INJECTION 10MG/ML 10ML VIAL 25S |
| NSN | 6505-00-254-5546 |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FUROSEMIDE TABLETS USP 40MG 500S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 40.000 MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT |